WHITEBOX ADVISORS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 175 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
WHITEBOX ADVISORS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$3,160,000
+17.2%
59,384
+3.4%
0.13%
+20.0%
Q3 2014$2,697,000
+229.7%
57,404
+337.1%
0.10%
+228.1%
Q2 2014$818,000
-78.3%
13,134
-81.7%
0.03%
-80.6%
Q4 2013$3,766,000
+101.6%
71,596
+65.9%
0.16%
+68.4%
Q3 2013$1,868,00043,1530.10%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders